首页> 外文期刊>RSC Advances >Magnetic-EpCAM nanoprobe as a new platform for efficient targeting, isolating and imaging hepatocellular carcinoma
【24h】

Magnetic-EpCAM nanoprobe as a new platform for efficient targeting, isolating and imaging hepatocellular carcinoma

机译:Magnetic-EpCAM纳米探针作为有效靶向,分离和成像肝细胞癌的新平台

获取原文
获取原文并翻译 | 示例
           

摘要

Herein, magnetic-EpCAM nanoparticle (EpCAM-MNP) was developed and exploited as nanoprobe for targeting, isolating and imaging hepatocellular carcinoma. The nanoprobe was composed of two major components including aminosilane-coated iron oxide nanoparticles and DNA-based EpCAM aptamers. Extensive studies were carried out to investigate its physico-chemical properties, magnetic relaxivity, as well as biocompatibility. The results indicated that the small size of the nanoprobe (HD < 100 nm) had high R-2 relaxivity with good biocompatibility. Study on cellular accumulation and cellular uptake demonstrated high accumulation of EpCAM-MNP that was internalized via receptor-mediated endocytosis, as evidenced by TEM analysis. By using a magnetic-activated cell sorting (MACS) approach, the majority (similar to 96%) of the HepG2 cells were isolated, indicating the feasibility of our nanoprobe for isolating EpCAM-positive cells in clinical application. Because of the high intracellular accumulation and the high R-2 relaxivity of EpCAM-MNP, it can be used for quantitative MRI detection of cancer cells with high sensitivity.
机译:在本文中,磁性-EpCAM纳米颗粒(EpCAM-MNP)被开发出来,并被用作靶向,分离和成像肝细胞癌的纳米探针。纳米探针由两个主要成分组成,包括氨基硅烷涂层的氧化铁纳米粒子和基于DNA的EpCAM适体。进行了广泛的研究以研究其理化性质,磁弛豫性以及生物相容性。结果表明,小尺寸的纳米探针(HD <100 nm)具有较高的R-2弛豫性和良好的生物相容性。细胞积累和细胞摄取的研究表明,EpCAM-MNP的高积累是通过受体介导的内吞作用而被内在化的,这通过TEM分析得以证明。通过使用磁激活细胞分选(MACS)方法,分离了大多数(约96%)的HepG2细胞,这表明我们的纳米探针在临床应用中分离EpCAM阳性细胞的可行性。由于EpCAM-MNP具有较高的细胞内蓄积性和R-2弛豫性,因此可用于以高灵敏度对癌细胞进行MRI定量检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号